Sutro Biopharma, Inc 10-Q for FY2025 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2025-08-07
For: 2025-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $63.75M
- up 148.0% from $25.71M a year earlier
- Net loss
- $11.5M
- compared with a net loss of $48.02M a year earlier
- Diluted EPS
- -$0.14
- compared with -$0.59 a year earlier